Atlas Trials

A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC

Clinical trial NCT05780294 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05780294
Sponsor
Sun Yat-sen University
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Nasopharyngeal CarcinomaLeucogenChemotherapyMyelosuppression
Start date
2023-04-01
Primary completion
2025-12-31
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.